Horizon Therapeutics

+$4.20 (+4.79%) As of 4:51 PM UTC today

Why Robinhood?

You can buy or sell HZNP and other stocks, options, and ETFs commission-free!

About HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares, also called Horizon Therapeutics, is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments.

CEO
Timothy P. Walbert
Employees
1,395
Headquarters
Dublin, Dublin
Founded
2008

HZNP Key Statistics

Market Cap
20.87B
Price-Earnings Ratio
74.56
Dividend Yield
—
Average Volume
1.68M
High Today
$91.97
Low Today
$87.74
Open Price
$88.32
Volume
589.20K
52 Week High
$97.20
52 Week Low
$43.81

HZNP Earnings

$0.03
$0.60
$1.17
$1.74
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.04 per share
Actual
$0.03 per share
Replay Earnings Call

You May Also Like

SVT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure